The role of muscle cells in regulating cartilage matrix production

Journal of Orthopaedic Research

Volumn 28, Issue 4, 2010, Pages 529-536

  Cairns, Dana M ^a   Lee, Philip G ^b   Uchimura, Tomoya ^b   Seufert, Christopher R ^b   Kwon, Heenam ^a   Zeng, Li ^a,b,c  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Chondrocytes; Matrix; Muscle

Indexed keywords

ALCIAN BLUE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; AGGRECAN; COLLAGEN TYPE 9; COLORING AGENT; GLYCOSAMINOGLYCAN; SCLEROPROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CELL FUNCTION; CHONDROGENESIS; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HOMEOSTASIS; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; TISSUE GROWTH; ANIMAL; ARTICULAR CARTILAGE; CATTLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHEMISTRY; CHICK EMBRYO; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MYOBLAST; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

AGGRECANS; ALCIAN BLUE; ANIMALS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHICK EMBRYO; CHONDROCYTES; COCULTURE TECHNIQUES; COLLAGEN TYPE II; COLLAGEN TYPE IX; COLORING AGENTS; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MYOBLASTS, SKELETAL; NIH 3T3 CELLS; RATS;

EID: 77949506258     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21014     Document Type: Article

References (57)

1. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
2. Sandell LJ, Adler P. 1999. Developmental patterns of cartilage. Front Biosci 4:D731-D742.
3. Hall BK, editor. 1983. Cartilage, 1st ed. Vol. 2 New York: Academic Press.
4. Blaschke UK, Eikenberry EF, Hulmes DJ, et al. 2000. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 275:10370-10378.
5. Freisinger P, Bonaventure J, Stoess H, et al. 1996. Type II collagenopathies: are there additional family members? Am J Med Genet 63:137-143.
6. Freisinger P, Ala-Kokko L, LeGuellec D, et al. 1994. Mutation in the COL2A1 gene in a patient with hypochondrogenesis. Expression of mutated COL2A1 gene is accompanied by expression of genes for type I procollagen in chondrocytes. J Biol Chem 269:13663-13669.
7. Lefkoe TP, Nalin AM, Clark JM, et al. 1997. Gene expression of collagen types IIA and IX correlates with ultrastructural events in early osteoarthrosis: new applications of the rabbit meniscectomy model. J Rheumatol 24:1155-1163.
8. BuckinghamM, Bajard L, Chang T, et al. 2003. The formation of skeletal muscle: from somite to limb. J Anat 202:59-68.
9. Stockdale FE, Nikovits W Jr, Christ B. 2000. Molecular and cellular biology of avian somite development. Dev Dyn 219: 304-321.
10. Drachman D, Sokoloff I. 1966. The role of movement in embryonic joint development. Dev Biol 14:401.
11. Deconinck AE, Rafael JA, Skinner JA, et al. 1997. Utrophin-hin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90:717-727.
12. Knapp JR, Davie JK, Myer A, et al. 2006. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 133:601-610.
13. Meadows E, Cho JH, Flynn JM, et al. 2008. Myogenin regulates a distinct genetic program in adult muscle stem cells. Dev Biol 322:406-414.
14. Rapaport D, Colletto GM, Vainzof M, et al. 1991. Short stature in Duchenne muscular dystrophy. Growth Regul 1:11-15.
15. Eiholzer U, Boltshauser E, Frey D, et al. 1988. Short stature: a common feature in Duchenne muscular dystrophy. Eur J Pediatr 147:602-605.
16. Crawford A, Dickinson SC. 2004. Chondrocyte isolation, expansion, and culture on polymer scaffolds. Methods Mol Biol 238:147-158.
17. Cairns DM, Sato ME, Lee PG, et al. 2008. A gradient of Shh establishes mutually repressing somitic cell fates induced by Nkx3. 2 and Pax3. Dev Biol 323:152-165.
18. Johnson RL, Laufer E, Riddle RD, et al. 1994. Ectopic expression of Sonic hedgehog alters dorsal-patterning of somites. Cell 79:1165-1173.
19. Zeng L, Kempf H, Murtaugh LC, et al. 2002. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16:1990-2005.
20. Morris JE, Ting YP. 1981. Comparison of proteoglycans extracted by saline and guanidinium chloride from cultured chick retinas. J Neurochem 37:1594-1602.
21. Bader D, Masaki T, Fischman DA. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 95:763-770.
22. Abramoff M, Magelhaes P, Ram S. 2004. Image processing with ImageJ. Biophotonics Int 11:36-42.
23. Girish V, Vijayalakshmi A. 2004. Affordable image analysis using NIH Image/ImageJ. Indian J Cancer 41:47.
24. Fagotto F, Jho E, Zeng L, et al. 1999. Domains of axin involved in protein- interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 145:741-756.
25. Boontheekul T, Hill EE, Kong HJ, et al. 2007. Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng 13:1431-1442.
26. Cimetta E, Flaibani M, Mella M, et al. 2007. Enhancement of viability of muscle precursor cells on 3D scaffold in a perfusion bioreactor. Int J Artif Organs 30:415-428.
27. Shansky J, Creswick B, Lee P, et al. 2006. Paracrine release of insulin-like growth factor 1 from a bioengineered tissue stimulates skeletal muscle growth in vitro. Tissue Eng 12: 1833-1841.
28. Lefebvre V, Smits P. 2005. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75:200-212.
29. Akiyama H, Kamitani T, Yang X, et al. 2005. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol 23:499-505.
30. Issack PS, Liu CJ, Prazak L, et al. 2004. A silencer element in the cartilage oligomeric matrix protein gene regulates chondrocyte-specific expression. J Orthop Res 22:751-758.
31. Hachisuka H, Mochizuki Y, Yasunaga Y, et al. 2007. Flow cytometric discrimination of mesenchymal progenitor cells from bone marrow-adherent cell populations using CD34/44/45(-) and Sca-1(+) markers. J Orthop Sci 12:161-169.
32. Kolupaeva V, Laplantine E, Basilico C. 2008. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 3: e 3447.
33. Krejci P, Masri B, Fontaine V, et al. 2005. Interaction of fibroblast growth factor and C-natriuretic. peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 118(Pt 21):5089-5100.
34. Krejci P, Salazar L, Goodridge HS, et al. 2008. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. J Cell Sci 121(Pt 3):272-281.
35. Priore R, Dailey L, Basilico C. 2006. Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J Cell Physiol 207:800-808.
36. Perkins GL, Derfoul A, Ast A, et al. 2005. An inhibitor of the stretch-activated cation receptor exerts a potent effect on chondrocyte phenotype. Differentiation 73:199-211.
37. Bar H, Strelkov SV, Sjoberg G, et al. 2004. The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? J Struct Biol 148:137-152.
38. Fischer L, Boland G, Tuan RS. 2002. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277:30870-30878.
39. Lassar A, Munsterberg A. 1994. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol 6:432-442.
40. Nowlan N, Murphy M, Prendergast PJ. 2008. A dynamic pattern of mechanical stiumulation promotes ossification in avian embryonic long bones. J Biomech 41:249-258.
41. Palacios J, Rodriguez JI, Ruiz A, et al. 1992. Long bone development in extrinsic fetal akinesia: an experimental study in rat fetuses subjected to oligohydramnios. Teratology 46:79-84.
42. Carter DR. 1987. Mechanical loading history and skeletal biology. J Biomech 20:1095-1109.
43. Kuo CK, Li WJ, Mauck RL, et al. 2006. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 18:64-73.
44. Tomczak KK, Marinescu VD, Ramoni MF, et al. 2004. Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 18:403-405.
45. Delgado I, Huang X, Jones S, et al. 2003. Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics 82:109-121.
46. Harridge SD. 2007. Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol 92:783-797.
47. Pedersen BK, Akerstrom TC, Nielsen AR, et al. 2007. Role of myokines in exercise and metabolism. J Appl Physiol 103: 1093-1098.
48. Kislinger T, Gramolini AO, Pan Y, et al. 2005. Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics 4:887-901.
49. Vadala G, Sobajima S, Lee JY, et al. 2008. In vitro interaction between muscle-derived stem cells and nucleus pulposus cells. Spine J 8:804-809.
50. Drachman DB. 1964. Atrophy of skeletal muscle in chick embryos treated with botulinum toxin. Science 145:719-721.
51. Okazaki K, Sandell LJ. 2004. Extracellular matrix gene regulation. Clin Orthop Relat Res 427(Suppl):S123-S128.
52. Wang W, Wang YG, Reginato AM, et al. 2004. Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice. Dev Biol 270:364-381.
53. Kawakami Y, Tsuda M, Takahashi S, et al. 2005. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci USA 102:2414-2419.
54. Taniguchi N, Yoshida K, Ito T, et al. 2007. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol 27:5650-5663.
55. Burrage PS, Mix KS, Brinckerhoff CE. 2006. Matrix metalloproteinases: role in arthritis. Front Biosci 11:529-543.
56. Burrage PS, Brinckerhoff CE. 2007. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets 8:293-303.
57. Glasson SS, Askew R, Sheppard B, et al. 2005. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644-658.